Peroxisomal disorders: clinical, biochemical, and molecular aspects.

This publication has 95 references indexed in Scilit:

• Refsum disease is caused by mutations in the phytanoyl–CoA hydroxylase gene
  Nature Genetics, 1997
• Identification of PAHX, a Refsum disease gene
  Nature Genetics, 1997
• Sterol Carrier Protein X (SCPx) Is a Peroxisomal Branched-Chain β-Ketothiolase Specifically Reacting with 3-Oxo-pristanoyl-CoA: A New, Unique Role for SCPx in Branched-Chain Fatty Acid Metabolism in Peroxisomes
  Biochemical and Biophysical Research Communications, 1997
• Nucleotide sequence of human alkyl-dihydroxyacetonephosphate synthase cDNA reveals the presence of a peroxisomal targeting signal 2
  Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1997
• Phytanoyl-CoA Hydroxylase Is Present in Human Liver, Located in Peroxisomes, and Deficient in Zellweger Syndrome: Direct, Unequivocal Evidence for the New, Revised Pathway of Phytanic Acid α-Oxidation in Humans
  Biochemical and Biophysical Research Communications, 1996
• Phenotype of patients with peroxisomal disorders subdivided into sixteen complementation groups
  The Journal of Pediatrics, 1995
• Phytanic acid must be activated to phytanoyl-CoA prior to its α-oxidation in rat liver peroxisomes
  Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1994
• L-Pipecolate oxidase: A distinct peroxisomal enzyme in man
  Biochemical and Biophysical Research Communications, 1989
• Pseudo-Zellweger syndrome: Deficiencies in several peroxisomal oxidative activities
  The Journal of Pediatrics, 1986
• Cerebro-hepato-renal syndrome
  The Journal of Pediatrics, 1967